טוען...
Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis
Background and aims: We examined the hypothesis of an anti-inflammatory effect of phosphatidylcholine in ulcerative colitis. Methods: A phase IIA, double blind, randomised, placebo controlled study was performed in 60 patients with chronic active, non steroid dependent, ulcerative colitis, with a cl...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Copyright 2005 by Gut
2005
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1774598/ https://ncbi.nlm.nih.gov/pubmed/15951544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2004.052316 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|